tiprankstipranks
pc:ensom

Ensoma

Ensoma is a biotechnology company focused on developing potentially curative medicines for genetic diseases, immune disorders, and cancer through in vivo hematopoietic stem cell (HSC) engineering. Utilizing proprietary base editing and high-efficiency gene integration systems, Ensoma's platform employs high-capacity virus-like particles (VLPs) to deliver genetic payloads directly to HSCs, enabling one-time administration of durable genetic therapies. The company is advancing its clinical-stage pipeline, including a Phase 1/2 trial for EN-374 targeting X-linked chronic granulomatous disease, and aims to make a global impact in the field of genetic medicines.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$53M
Total Amount Raised$53M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$53M
Latest Funding Amount$53M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 22, 2025
Investment
$53.00M

Investors

Investor Name
Funding Round

Related News and Analysis